KORU Medical Systems does not distribute cash dividends to its common shareholders, resulting in a dividend yield of zero. As an emerging medical technology enterprise focused heavily on scaling commercial operations, expanding domestic and international distribution channels, and funding ongoing research and development pipelines, management reinvests all available capital back into the business to drive long-term corporate growth.